LAGHENO
Live / Applied — Fourth extension granted (statement of use) (as of 24 Apr 2025)
What this means for you
Not registered yet, but its 26 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97430578
- Mark type
- Stylized text
- Filed
- 26 May 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 4 GRANTED
- 24 Apr 2025 — SOU EXTENSION 4 FILED
- 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 3 GRANTED
- 31 Oct 2024 — SOU EXTENSION 3 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2024 — SOU EXTENSION 2 GRANTED
- 25 Apr 2024 — SOU EXTENSION 2 FILED
- 25 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2023 — SOU EXTENSION 1 GRANTED